Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | TTR | P02766 | 1/20 | 0.37 |
| ▸ | ALB | P02768 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.35 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.35 |
| ▸ | SETDB1 | Q15047 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1232549 | 0.88 | ALDH1A1 (0.38) | FFAR1ALDH1A1MAPTCYP3A4KMT2A | |
| SCHEMBL24129394 | 0.80 | MEN1 (0.44) | FFAR1ALDH1A1MAPTCYP3A4KMT2A | |
| SCHEMBL28640226 | 0.79 | ALDH1A1 (0.43) | ALDH1A1MAPTCYP3A4KMT2AMEN1 | |
| SCHEMBL31019228 | 0.79 | ALDH1A1 (0.43) | ALDH1A1MAPTCYP3A4KMT2AMEN1 | |
| SCHEMBL20568243 | 0.78 | PARP15 (0.43) | FFAR1ALDH1A1MAPTKMT2AMEN1 | |
| SCHEMBL30427245 | 0.78 | PARP15 (0.43) | FFAR1ALDH1A1MAPTKMT2AMEN1 | |
| SCHEMBL16585049 | 0.78 | ALDH1A1 (0.42) | ALDH1A1MAPTKMT2AGSK3BTDP1 | |
| SCHEMBL4655268 | 0.78 | CYP3A4 (0.55) | ALDH1A1MAPTCYP3A4KMT2AMEN1 | |
| SCHEMBL8114634 | 0.77 | VCAM1 (0.49) | ALDH1A1MAPTKMT2AMEN1MAOB | |
| SCHEMBL2177944 | 0.77 | PKM (0.40) | ALDH1A1MAPTCYP3A4KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220184184-A1 | GLUCOSE SENSITIVE INSULIN DERIVATIVES | NOVO NORDISK A/S (DK) | 2022-06-16 | — | — | US | disclosed |
| EP-3946363-A2 | GLUCOSE SENSITIVE INSULIN DERIVATIVES | Novo Nordisk A/S (DK) | 2022-02-09 | — | — | EP | disclosed |
| WO-2020201041-A2 | GLUCOSE SENSITIVE INSULIN DERIVATIVES | NOVO NORDISK A/S (DK) | 2020-10-08 | — | — | WO | disclosed |
| US-10314308-B2 | Microbiocidal benzoxaboroles | SYNGENTA PARTICIPATIONS AG (CH) | 2019-06-11 | — | — | US | disclosed |
| US-10314308-B2 | Microbiocidal benzoxaboroles | SYNGENTA PARTICIPATIONS AG (CH) | 2019-06-11 | — | — | US | disclosed |
| US-20180000090-A1 | MICROBIOCIDAL BENZOXABOROLES | SYNGENTA PARTICIPATIONS AG (CH) | 2018-01-04 | — | — | US | disclosed |
| US-20180000090-A1 | MICROBIOCIDAL BENZOXABOROLES | SYNGENTA PARTICIPATIONS AG (CH) | 2018-01-04 | — | — | US | disclosed |
| EP-3245214-A1 | MICROBIOCIDAL BENZOXABOROLES | Syngenta Participations AG (CH) | 2017-11-22 | — | — | EP | disclosed |
| WO-2016113303-A1 | MICROBIOCIDAL BENZOXABOROLES | SYNGENTA PARTICIPATIONS AG (CH) | 2016-07-21 | — | — | WO | disclosed |
| WO-2016113303-A1 | MICROBIOCIDAL BENZOXABOROLES | SYNGENTA PARTICIPATIONS AG (CH) | 2016-07-21 | — | — | WO | disclosed |
| US-20110207701-A1 | BORON-CONTAINING SMALL MOLECULES AS ANTIPROTOZOAL AGENTS | ANACOR PHARMACEUTICALS, INC. (US) | 2011-08-25 | — | — | US | disclosed |
| US-20110207701-A1 | BORON-CONTAINING SMALL MOLECULES AS ANTIPROTOZOAL AGENTS | ANACOR PHARMACEUTICALS, INC. (US) | 2011-08-25 | — | — | US | disclosed |
| WO-2011022337-A1 | BORON-CONTAINING SMALL MOLECULES AS ANTIPROTOZOAL AGENTS | ANACOR PHARMACEUTICALS, INC. (US) | 2011-02-24 | — | — | WO | disclosed |
| WO-2011022337-A1 | BORON-CONTAINING SMALL MOLECULES AS ANTIPROTOZOAL AGENTS | ANACOR PHARMACEUTICALS, INC. (US) | 2011-02-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220184184-A1 | GLUCOSE SENSITIVE INSULIN DERIVATIVES | IAPP, IRS1, GPR119 | FFAR1 346/4885ALDH1A1 3266/4885MAPT 1830/4885 |
| US-20180000090-A1 | MICROBIOCIDAL BENZOXABOROLES | MPO, MANBA, BROX | FFAR1 1422/4885ALDH1A1 1114/4885MAPT 3662/4885 |
| US-10314308-B2 | Microbiocidal benzoxaboroles | MPO, MANBA, BROX | FFAR1 1422/4885ALDH1A1 1114/4885MAPT 3662/4885 |
| US-20110207701-A1 | BORON-CONTAINING SMALL MOLECULES AS ANTIPROTOZOAL AGENTS | BTD, BAD, BRI3BP | FFAR1 4642/4885ALDH1A1 4684/4885MAPT 3310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.